BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+16.96%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.82B
AUM Growth
+$366M
(+25%)
Cap. Flow
+$143M
Cap. Flow
% of AUM
7.84%
Top 10 Holdings %
Top 10 Hldgs %
36.79%
Holding
154
New
14
Increased
81
Reduced
30
Closed
17
Top Buys
| 1 |
Humana
HUM
|
$19.6M |
| 2 |
Evolent Health
EVH
|
$17.1M |
| 3 |
Teladoc Health
TDOC
|
$16.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$9.97M |
| 5 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$9.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$60.4M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$6.49M |
| 3 |
Amgen
AMGN
|
$5.79M |
| 4 |
MacroGenics
MGNX
|
$4.97M |
| 5 |
Insmed
INSM
|
$4.35M |
Sector Composition
| 1 | Healthcare | 91.36% |
| 2 | Industrials | 1.12% |
| 3 | Technology | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
101
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.44M | 0.13% |
+47,200
| New | +$2.44M |
|
102
uniQure
QURE
$973M
| $2.29M | 0.13% |
38,300
+28,300
| +283% | +$1.69M |
|
|
PTLA
103
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.16M | 0.12% |
62,300
+36,650
| +143% | +$1.27M |
|
104
Ascendis Pharma
ASND
$12B
| $2.14M | 0.12% |
+18,200
| New | +$2.14M |
|
|
ARNA
105
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.1M | 0.12% |
46,917
+16,600
| +55% | +$744K |
|
|
GWPH
106
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.08M | 0.11% |
12,353
+5,924
| +92% | +$998K |
|
107
Ultragenyx Pharmaceutical
RARE
$3.01B
| $2.07M | 0.11% |
29,800
+7,600
| +34% | +$527K |
|
108
Amicus Therapeutics
FOLD
$2.47B
| $2.04M | 0.11% |
+150,000
| New | +$2.04M |
|
109
Biogen
BIIB
$20.5B
| $2M | 0.11% |
8,450
-16,800
| -67% | -$3.97M |
|
|
ICPT
110
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.93M | 0.11% |
17,227
-5,921
| -26% | -$662K |
|
111
Regenxbio
RGNX
$476M
| $1.9M | 0.1% |
33,100
+9,800
| +42% | +$562K |
|
112
Neurocrine Biosciences
NBIX
$13.9B
| $1.78M | 0.1% |
20,200
-19,850
| -50% | -$1.75M |
|
113
AngioDynamics
ANGO
$436M
| $1.73M | 0.1% |
75,700
| – | – |
|
114
Insulet
PODD
$24.4B
| $1.71M | 0.09% |
18,000
| – | – |
|
115
Pfizer
PFE
$140B
| $1.7M | 0.09% |
+42,160
| New | +$1.7M |
|
|
CELG
116
DELISTED
Celgene Corp
CELG
| $1.68M | 0.09% |
17,788
-639,813
| -97% | -$60.4M |
|
117
Amneal Pharmaceuticals
AMRX
$3B
| $1.42M | 0.08% |
100,000
+5,000
| +5% | +$70.9K |
|
118
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$60.5M
| $1.38M | 0.08% |
+3,750
| New | +$1.38M |
|
119
PTC Therapeutics
PTCT
$4.61B
| $1.31M | 0.07% |
34,700
+13,000
| +60% | +$489K |
|
120
Merck
MRK
$210B
| $1.25M | 0.07% |
15,720
| – | – |
|
|
RDUS
121
DELISTED
Radius Health, Inc.
RDUS
| $1.18M | 0.06% |
+59,100
| New | +$1.18M |
|
|
ARRY
122
DELISTED
Array Biopharma Inc
ARRY
| $1.18M | 0.06% |
+48,200
| New | +$1.18M |
|
|
BNFT
123
DELISTED
Benefitfocus, Inc.
BNFT
| $1.14M | 0.06% |
+22,979
| New | +$1.14M |
|
124
Premier
PINC
$2.17B
| $1.09M | 0.06% |
31,462
+18,062
| +135% | +$623K |
|
125
Sarepta Therapeutics
SRPT
$1.93B
| $1.09M | 0.06% |
9,100
-3,600
| -28% | -$429K |
|